Our data indicate that while a decrease in E-cadherin is generally a useful prognostic biomarker in different epithelial tumour types, loss of ZNF185 is strongly associated with late tumour stages and poorly differentiated head and neck, possibly oesophageal and cervical, SCC tumours. Here, ZNF185 is linked to neoplasm.